Journal ArticleJ Cardiovasc Electrophysiol · April 2025
BACKGROUND: The majority of data on left bundle branch area pacing (LBBAP) are on a lumenless lead. Data on the safety and effectiveness of stylet driven leads are comparatively lacking. METHODS: We retrospectively analyzed 265 patients who underwent attem ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · February 2025
BACKGROUND: Implantable cardioverter-defibrillator (ICD) shocks are a common complication after left ventricular assist device (LVAD) implantation; however, data on their frequency and causes are limited. OBJECTIVE: The purpose of this study was to define ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · July 2023
INTRODUCTION: Accurate localization of septal outflow tract premature ventricular contractions (PVCs) is often difficult due to frequent mid-myocardial or protected origin. Compared with traditional activation mapping, CARTO Ripple mapping provides visuali ...
Full textLink to itemCite
Journal ArticleAnn Noninvasive Electrocardiol · July 2022
BACKGROUND: Atrial pacing and right ventricular (RV) pacing are both associated with adverse outcomes among patients with first-degree atrioventricular block (1°AVB). His-bundle pacing (HBP) provides physiological activation of the ventricle and may be abl ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · August 2021
BACKGROUND: Ventricular arrhythmias (VAs) and electrical storm (ES) are recognized complications following left ventricular assist device (LVAD) implantation; however, their association with long term-outcomes remains poorly understood. OBJECTIVE: The purp ...
Full textLink to itemCite
Journal ArticleCurr Hypertens Rep · October 23, 2020
PURPOSE OF REVIEW: To highlight the indications, procedural considerations, and data supporting the use of stellate ganglion blockade (SGB) for management of refractory ventricular arrhythmias. RECENT FINDINGS: In patients with refractory ventricular arrhy ...
Full textOpen AccessLink to itemCite
Journal ArticleHeart Rhythm · September 2020
BACKGROUND: There are limited data on the performance of the subcutaneous implantable cardioverter-defibrillator (S-ICD) in patients with a left ventricular assist device (LVAD). OBJECTIVE: The purpose of this study was to describe the clinical course and ...
Full textLink to itemCite
Journal ArticleHeart Rhythm O2 · August 2020
BACKGROUND: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM. OBJECTIVE: The purpose of this study was to compa ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · February 2020
BACKGROUND: Pulmonary wall isolation (PWI) is increasingly used as an adjunctive lesion set to compliment pulmonary vein isolation (PVI), especially in patients with persistent atrial fibrillation (AF). The objective was to compare outcomes of catheter abl ...
Full textLink to itemCite
Journal ArticleJ Arrhythm · February 2020
BACKGROUND: Catheter ablation is an important rhythm control therapy in patients with atrial fibrillation (AF) with concomitant heart failure (HF). The objective of this study was to assess the comparative efficacy of AF ablation patients with ischemic vs ...
Full textOpen AccessLink to itemCite
Journal ArticlePacing Clin Electrophysiol · November 2019
BACKGROUND: Compared with medical therapy, catheter ablation of atrial fibrillation (AF) in patients with heart failure (HF) improves cardiovascular outcomes. Risk scores (CAAP-AF and APPLE) have been developed to predict the likelihood of AF recurrence af ...
Full textOpen AccessLink to itemCite
Journal ArticleHeart Rhythm · May 2018
BACKGROUND: Few studies have examined outcomes of catheter ablation for atrial fibrillation (AF) in patients with heart failure (HF) with preserved ejection fraction (HFpEF). OBJECTIVE: The purpose of this study was to compare outcomes of AF ablation in pa ...
Full textLink to itemCite
Journal ArticleJ Electrocardiol · 2017
We report the case of a 57-year-old man with a history of ischemic cardiomyopathy who presented to the hospital with recurrent episodes of ventricular tachycardia refractory to antiarrhythmic medications. Mapping identified a deep premature ventricular con ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · June 2015
BACKGROUND: Restoration of sinus rhythm (SR) in patients with atrial fibrillation/atrial flutter (AF/AFL) is limited principally to direct current cardioversion. The multi-ion channel blocker vanoxerine may prove an effective alternative. OBJECTIVE: The pu ...
Full textLink to itemCite
Journal ArticleUltrason Imaging · April 2014
We have previously shown that intracardiac acoustic radiation force impulse (ARFI) imaging visualizes tissue stiffness changes caused by radiofrequency ablation (RFA). The objectives of this in vivo study were to (1) quantify measured ARFI-induced displace ...
Full textOpen AccessLink to itemCite
Journal ArticlePacing Clin Electrophysiol · May 2013
BACKGROUND: Proper positioning of the left ventricular (LV) lead improves clinical outcomes and survival in patients receiving cardiac resynchronization therapy (CRT). Techniques of LV lead insertion using contrast injection and a telescoping system of del ...
Full textLink to itemCite
ConferenceIEEE International Ultrasonics Symposium Ius · December 1, 2012
Recurrence of atrial fibrillation after transcatheter ablation (TCA) is common because there is no imaging modality that can visually confirm the presence of radiofrequency ablation (RFA) lesions. We have previously shown that acoustic radiation force impu ...
Full textCite
Journal ArticleHeart Rhythm · November 2012
BACKGROUND: Arrhythmia recurrence after cardiac radiofrequency ablation (RFA) for atrial fibrillation has been linked to conduction through discontinuous lesion lines. Intraprocedural visualization and corrective ablation of lesion line discontinuities cou ...
Full textOpen AccessLink to itemCite
Journal ArticleEuropace · December 2011
AIMS: Chronic kidney disease (CKD) is increasingly prevalent, and is an independent risk factor for cardiovascular mortality. Clinical trials of the implantable cardioverter-defibrillator (ICD) have demonstrated a survival benefit over medical therapy for ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · October 2011
Use of VSTAP to Facilitate Hemodynamic Support. The ablation of hemodynamically unstable ventricular tachycardia (VT) is challenging and frequently requires alternative mapping techniques or the use of percutaneous mechanical support devices. Loss of atrio ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Genet · April 2011
BACKGROUND: Risk-stratifying heart failure patients for primary prevention implantable cardioverter-defibrillators (ICDs) remains a challenge, especially for blacks, who have an increased incidence of sudden cardiac death but have been underrepresented in ...
Full textLink to itemCite
OtherN Engl J Med · March 24, 2011
To the Editor: We would like to retract our article, "A Genomic Strategy to Refine Prognosis in Early-Stage Non-Small-Cell Lung Cancer,"(1) which was published in the Journal on August 10, 2006. Using a sample set from a study by the American College of Su ...
Full textLink to itemCite
Journal ArticleAm Heart J · November 2009
BACKGROUND: Disturbances in cardiac rhythm can lead to significant morbidity and mortality. Many arrhythmias are known to have a heritable component, but the degree to which genetic variation contributes to disease risk and morbidity is poorly understood. ...
Full textLink to itemCite
Journal ArticleMed Dosim · 2009
Adjuvant radiotherapy for locally advanced prostate cancer improves biochemical and clinical disease-free survival. While comparisons in intact prostate cancer show a benefit for intensity modulated radiation therapy (IMRT) over 3D conformal planning, this ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · December 11, 2007
Polycomb group genes (PcGs) have been implicated in cancer based on altered levels of expression observed in certain tumors and the behavior of cultured cells containing inserted PcG transgenes. Endometrial stromal tumors provide evidence for a direct caus ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · January 2007
Nonrandom cytogenetic abnormalities of chromosomes 6, 7, and 17 have been reported within low-grade endometrial stromal sarcomas (LGESSs), and among these abnormalities, the t(7;17)(p15;q21) is the most common aberration described. Previously we had shown ...
Full textLink to itemCite
Journal ArticleN Engl J Med · August 10, 2006
BACKGROUND: Clinical trials have indicated a benefit of adjuvant chemotherapy for patients with stage IB, II, or IIIA--but not stage IA--non-small-cell lung cancer (NSCLC). This classification scheme is probably an imprecise predictor of the prognosis of a ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · May 22, 2001
Endometrial stromal tumors are divided into three types: benign stromal nodules, endometrial stromal sarcomas, and undifferentiated endometrial sarcomas. A variety of cytogenetic abnormalities involving chromosome 7 have been reported in endometrial stroma ...
Full textLink to itemCite
Journal ArticleCancer Res · December 15, 1999
Lymphomas arising in mucosa-associated lymphoid tissue (MALT) are indolent B-cell tumors that have a predilection for epithelial sites and often develop in a setting of chronic inflammation or autoimmunity. As many as 50% of low-grade MALT lymphomas contai ...
Link to itemCite
Journal ArticleNat Genet · February 1995
We have explored the application of the bacteriophage resolvases T4 endonuclease VII and T7 endonuclease I for detecting mutations in genomic DNA. Heteroduplex DNA fragments prepared by amplification from DNA containing known mutations were cleaved by one ...
Full textLink to itemCite
Journal ArticleJournal of the American Chemical Society · January 1, 1995
A series of 7-azabicyclo[2.2.1]hept-5-ene complexes are prepared from [Os(NH3)5(η2-L)]2+ (L = pyrrole, 1-methylpyrrole, 2,5-dimethylpyrrole, 1,2,5-trimethylpyrrole, or 1-(trimethylsilyl)pyrrole) and various dipol ...
Full textCite
Journal ArticleJournal of Organic Chemistry · January 1, 1995
The reactivity of a series of pyrrole complexes of the form [Os(NH3)5(4,5-2-L)]2+(OTf)2 (L = pyrrole and alkylated pyrroles) is surveyed with various electrophiles. The pyrrole ligand undergoes alkylat ...
Full textCite
Journal ArticleJournal of Organic Chemistry · January 1, 1993
η2-Pyrrole complexes, readily generated from the corresponding pyrrole and Os(NH3)5(OTf)3, are combined with Michael acceptors under appropriate conditions to yield selectively α- or β-substituted 1H-pyrroles or ...
Full textCite
Journal ArticleJournal of the American Chemical Society · July 1, 1992
A series of complexes is synthesized of the form [Os(NH3)5(2,3-η2-pyrrole)]2+, with pyrrole and various alkylated pyrroles. In contrast to the free ligands, these complexes can be protonated chemo- and stereosele ...
Full textCite